The history of Sildenafil presents a challenging picture for those considering investment. While the initial introduction generated significant profits, the end of its exclusive rights opened the avenue to off-brand alternatives, dramatically diminishing revenue. This creates a unique challenge for drug manufacturers relying on similar blockbuster

The legacy of Viagra, and its parent company copyright, presents a intriguing case study for investors. Originally a blockbuster drug, generating billions in sales , its intellectual property lapse created a wave of lower-priced alternatives , significantly impacting its dominance. While some businesses may try to capitalize on related treatments ,